Impact of specific Epidermal Growth Factor Receptor (EGFR) mutations and clinical characteristics on outcomes after treatment with EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR-mutant lung cancer: A meta-analysis

Chee Khoon Lee, Yi-Long Wu, Pei Ni Ding, Sarah J Lord, A. Inoue, Caicun Zhou , Tetsuya Mitsudomi, Rafael Rosell, Nick Pavlakis, Matthew Links, Val Gebski, Richard J Gralla, James Chih-Hsin Yang*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

294 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Impact of specific Epidermal Growth Factor Receptor (EGFR) mutations and clinical characteristics on outcomes after treatment with EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR-mutant lung cancer: A meta-analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences